Eleven Biotherapeutics Announces Additional Financing of $20 Million – FierceBiotech

Eleven Biotherapeutics Announces Additional Financing of $20 Million
FierceBiotech
The investment in Eleven consists of the sale and issuance of 1,743,680 shares of common stock at $11.47 per share, the closing bid price reported by NASDAQ on November 24, 2014, as well as the sale and issuance of warrants to purchase approximately …

and more

…read more

Scroll to Top